PD Dr. Paul Gaß

Department of Obstetrics and Gynaecology Medizinische Fakultät

The Epidemiology of Cervical Cancer in Germany: A Registry-Based Analysis of Incidence, Survival, and Tumor Characteristics (2003–2021) (2025) Stübs F, Beckmann M, Pöschke P, Heindl F, Emons J, Gaß P, Häberle L Journal article Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study (2025) Jaeger A, Hampl M, Prieske K, Eulenburg C, Reichenbach J, Klapdor R, Heublein S, et al. Journal article Prognostic Significance of Macrophage Phenotypes in Peri-Tumoral Normal Tissue of Early-Stage Breast Cancer (2025) Hirschmann M, Schnellhardt S, Rübner M, Segelhorst S, Ott O, Erber R, Daniel C, et al. Journal article Correction to: Evaluation of endocervical curettage (ECC) in colposcopy for detecting cervical intraepithelial lesions (Archives of Gynecology and Obstetrics, (2024), 310, 6, (3037-3045), 10.1007/s00404-024-07721-w) (2025) Behrens A, Dietl A, Adler W, Geppert CI, Hartmann A, Knöll A, Beckmann M, et al. Journal article, Erratum Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women (2025) Stübs F, Dietl A, Schulmeyer C, Behrens A, Seibold A, Brückner L, Schleicher O, et al. Journal article Sentinel Lymphonodectomy in Early Vulvar Cancer in Daily Practice: a Multicenter Experience from Germany Sentinel-Lymphonodektomie bei Vulvakrebs im Frühstadium in der täglichen Praxis: eine multizentrische Erfahrung aus Deutschland (2025) Soergel P, Hempel M, Gallwas J, Dannecker C, Woelber L, Klapdor R, Hantschmann P, et al. Journal article Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers. (2025) Häberle L, Erber R, Gaß P, Hein A, Niklos M, Volz B, Hack C, et al. Journal article Kolposkopie der Vulva: Wann, wie, wie oft? (2025) Behrens A, Beckmann M, Gaß P, Schulmeyer C, Seibold A, Dietl A, Stübs F Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer (2024) Seitz K, Goossens C, Hübner H, Gaß P, Uhrig S, Heindl F, Emons J, et al. Journal article